Sentence examples for on assay development from inspiring English sources

In her role, Yulia manages multiple cell-based assays, working on assay development and optimization, small molecule and siRNA screening, and imaging and image analysis.

Instead of relying solely on assay development experience and intuition to improve assay sensitivity, this systematic approach takes advantage of a predictive mathematical model generated through response surface methods that defines a specific path towards greater predicted assay sensitivity.

Todd landed a position as a research scientist at Rigel Pharmaceuticals, a biotechnology company with 120 employees, where he worked on assay development for drug targets and did experimental biochemistry.

Commercial kits are typically delivered with specialized software automating data processing such as Skyline (MacCoss Lab of Biological Mass Spectrometry, University of Washington, Seattle, WA, USA) [7], which does not require the studying of complex software documentation and is focused on assay development and subsequent results analysis in "plug-and-play" mode.

Recent studies on assay development for prediction of sensitization in vitro have to a large extent focused on how danger signals are provided to antigen-presenting cells, inducing pro-inflammatory cytokines and chemokines, as well as co-stimulatory molecules needed for a specific T-cell response.

The benefit of this in terms of assay development is that the sensitivity of an assay depends strongly on the signal-to-background ratio that can be achieved.

In this paper, we illustrate certain unique applications of these pumps such as sample injection, fluid flow in packed bed, and on-chip assay development, all of which are relevant to point-of-care diagnostic device design and fabrication.

Our approach to affinity ligand design for assay development was based on a structural understanding of the binding mode between small molecule and target.

The final selection of the monoclonal antibody for assay development was based on high reactivity towards its free peptide and towards serum samples from patients diagnosed with IPF (ProteoGenex, Culver City, CA, USA) combined with low reactivity towards their elongated peptide and intact elastin.

The lead time for assay development and validation depends greatly on the assay platform and the complexity of the assay.

The further analysis and detailed results of these mutants as well as their impact on biophysical assay development for drug discovery can be found in "Method for Rapid Optimization of Recombinant GPCR Protein Expression and Stability using Virus-Like Particles" (Ho et al., 2017) [2].